Antiretroviral-drug concentrations in semen: Implications for sexual transmission of human immunodeficiency virus type 1

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 8, 1999, Pages 1817-1826

  Kashuba, Angela D M ^a   Dyer, John R ^b,c   Kramer, Linda M ^a   Raasch, Ralph H ^a   Eron, Joseph J ^b   Cohen, Myron S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c St Andrew's Ipswich Private Hospital   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

DISEASE MODEL; DISSOCIATION CONSTANT; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG SEMEN LEVEL; GENITAL SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

EID: 0032839482     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.8.1817     Document Type: Short Survey

References (141)

1. Amann, R. P. 1986. Detection of alterations in testicular and epididymal function in laboratory animals. Environ. Health Perspect. 70:149-158.
2. Anderson, D. J., T. R. O'Brien, J. A. Politch, A. Martinez, G. R. Seage III, N. Padian, R. Horsburgh, Jr., and K. H. Mayer. 1992. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA 267:2769-2774.
3. Armstrong, J. R., F. E. Cook, and J. R. Robinson. 1968. Concentration of antibiotic and chemotherapeutic agents in the ejaculum. J. Urol. 100:72-76.
4. Aumuller, G., J. Seitz, H. Lilja, P. A. Abrahamsson, H. von der Kammer, and K. H. Scheit. 1990. Species-and organ-specificity of secretory proteins derived from human prostate and seminal vesicles. Prostate 17:31-40.
5. Baggot, J. D. 1992. Clinical pharmacokinetics in veterinary medicine. Clin. Pharmacokinet. 22:254-273.
6. Balzarini, J. H., H. Pelemann, A. Karlsson, E. de Clercq, and J.-P. Kleim. 1996. Concomitant combination therapy for HIV infection preferable over sequential therapy with 3TC and non-nucleoside reverse transcriptase inhibitors. Proc. Natl. Acad. Sci. USA 93:13152-13157.
7. Barry, M. G., S. H. Khoo, G. J. Veal, P. G. Hoggard, S. E. Gibbons, E. G. L. Wilkins, O. Williams, A. M. Breckenridge, and D. J. Back. 1996. The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites. AIDS 10:1361-1367.
8. Battersby, S., J. A. Chandler, M. E. Harper, and N. J. Blacklock. 1977. The ultrastructure of rhesus monkey prostate. Urol. Res. 5:175-183.
9. Bendenelli, M., M. Pistello, S. Lombardi, A. Poli, C. Garzelli, D. Matteucci, L. Ceccherini-Nelli, G. Malvaldi, and F. Tozzini. 1995. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8:87-112.
10. Berger, E. A., R. W. Doms, E-M. Fenyo, B. T. M. Korber, D. R. Littman, J. P. Moore, Q. J. Sattentau, H. Schuitemaker, J. Sodroski, and R. A. Weiss. 1998 A new classification for HIV-1. Nature 391:240.
11. Busch, M. P., E. A. Operskalski, J. W. Mosley, T. H. Lee, D. Henrard, S. Herman, D. H. Sachs, M. Harris, W. Huang, and D. O. Stram. 1996. Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. J. Infect. Dis. 174:26-33.
12. Byrn, R. A., D. Zhang, R. Eyre, K. McGowan, and A. A. Kiessling. 1997. HIV-1 in semen: an isolated virus reservoir. Lancet 350:1141.
13. Cates, W., M. Chesney, and M. S. Cohen. 1997. Primary HIV disease: a public health emergency. Am. J. Public Health 87:1928-1930.
14. Cavert, W., D. W. Notermaans, K. Staskus, S. W. Wietgrefe, M. Zupancic, K. Gebhard, K. Henry, Z.-Q. Zhang, R. Mills, H. McDade, J. Goudsmit, S. A. Danner, and A. T. Haase. 1997. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276:960-964.
15. Chauret, N., A. Gauthier, J. Martin, and D. A. Nicoll-Griffith. 1997. In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metab. Dispos. 25:1130-1136.
16. Ciaccio, P. J., and J. R. Halpert. 1989. Characterization of a phenobarbital-inducible dog liver cytochrome P450 structurally related to rat and human enzymes of the P450IIIA (steroid-inducible) gene subfamily. Arch. Biol. Biophys. 271:284-299.
17. Cohen, M. S., G. Dallabetta, W. Cates, Jr., and K. K. Holmes. The global prevention of HIV. In M. A. Sande and P. A. Volberding (ed.), The medical management of AIDS, in press. The W. B. Saunders Co., Philadelphia, Pa.
18. Cohen, M. S., G. Dallabetta, M. Laga, and K. K. Holmes. 1994. A new deal in HIV prevention: lessons from the global approach. Ann. Intern. Med. 120:340-341.
19. Coombs, R. W., C. E. Speck, J. P. Hughes, W. Lee, R. Sample, S. O. Ross, J. Dragoon, G. Peterson, T. M. Houghton, A. C. Collier, L. Corey, L. Koutsky, and J. N. Krieger. 1998. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood - evidence for compartmentalization of HIV-1 between semen and blood. J. Infect. Dis. 177:320-330.
20. Daniel, M. S. M., R. C. Desrosiers, N. L. Letvin, N. W. King, D. K. Schmidt, P. Sehgal, and R. D. Hunt. 1987. Simian models for AIDS. Cancer Detect. Prev. Suppl. 1:501-507.
21. Deeks, S. G., M. Smith, M. Holodniy, and J. O. Kahn. 1997. HIV-1 protease inhibitors: a review for clinicians. JAMA 277:145-153.
22. Delwart, E. L., H. Pan, A. Neumann, and M. Markowitz. 1998. Rapid transient changes at the env locus of plasma human immunodeficiency virus type 1 populations during the emergence of protease inhibitor resistance. J. Virol. 72:2416-2421.
23. Delwart, E. L., J. I. Mullins, P. Gupta, G. H. Learn Jr., M. Holodniy, D. Katzenstein, B. D. Walker, and M. K. Singh. 1998. Human immunodeficiency virus type 1 populations in blood and semen. J. Virol. 72:617-623.
24. deSousa, G., N. Florence, B. Valles, P. Coassolo, and R. Rahmani. 1995. Relationships between in vitro and in vivo biotransformation of drugs in humans and animals: pharmaco-toxicological consequences. Cell Biol. Toxicol. 11:147-153.
25. Dube, J. Y., G. Frenette, P. Chapdelaine, R. Paquin, and R. R. Tremblay. 1985. Biochemical characteristics of the proteins secreted by dog prostate, a review. Exp. Biol. 43:149-159.
26. Dyer, J. R., B. L. Gilliam, J. J. Eron, Jr., L. Frosso, M. S. Cohen, and S. A. Fiscus. 1996. Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture. J. Virol. Methods 60:161-170.
27. Dyer, J. R., B. L. Gilliam, J. J. Eron, Jr., M. S. Cohen, S. A. Fiscus, and P. L. Vernazza. 1997. Shedding of HIV-1 in semen during primary infection. AIDS 11:543-545.
28. English, R. V., C. M. Johnson, D. H. Gebhard, and M. B. Tompkins. 1993. In vivo lymphocyte tropism of feline immunodeficiency virus. J. Virol. 67:5175-5186.
29. Erice, A., D. L. Mayers, D. G. Strike, K. J. Sannerud, F. E. McCutchan, and H. K. Balfour, Jr. 1993. Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N. Engl. J. Med. 328:1163-1165.
30. Eron, J. J., S. L. Benoit, J. Jemsek, R. D. MacArthur, J. Santana, J. B. Quinn, D. R. Kuritzkes, M. A. Fallon, and M. Rubin for the North American HIV Working Party. 1995. Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200-500 CD4+ cells per cubic millimeter. N. Engl. J. Med. 333:1662-1669.
31. Eron, J. J., P. L. Vernazza, D. M. Johnston, F. Seillier-Moiseiwitsch, T. M. Alcorn, S. A. Fiscus, and M. S. Cohen. 1998. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS 12:F181-F189.
32. Fiennes, W. (ed.). 1972. Pathology of simian primates. S. Karger, Basel, Switzerland.
33. Fiore, J. R., Y.-J. Zhang, A. Bjorndal, M. di Stefano, G. Angarano, G. Pastore, and E. M. Fenyo. 1997. Biological correlates of HIV-1 heterosexual transmission. AIDS 11:1089-1094.
34. Fordney Settlage, D. S., and A. G. Hendrickx. 1974. Observations on coagulum characteristics of the rhesus monkey electroejaculate. Biol. Reprod. 11:619-623.
35. Fung, G., H. Burger, R. Grimson, P. Tropper, S. Nachman, D. Mayers, O. Weislow, R. Moore, C. Reyelt, and N. Hutcheon. 1995. Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc. Natl. Acad. Sci. USA 92:12100-12104.
36. Gardner, M. B. 1990. SIV infection of macaques: a model for AIDS vaccine development. Dev. Biol. Stand. 72:259-266.
37. Gardner, M. B. 1991. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents. Antivir. Res. 15:267-286.
38. Gilliam, B. L., J. R. Dyer, S. A. Fiscus, C. Marcus, W. Freimuth, M. S. Cohen, and J. J. Eron, Jr. 1997. Effect of reverse transcriptase inhibitor therapy on HIV-1 viral burden in semen. J. Acquired. Immune Defic. Syndr. Hum. Retrovirol. 15:54-60.
39. Goodrowe, K. L., J. G. Howard, P. M. Schmidt, and D. E. Wildt. 1989. Reproductive biology of the domestic cat with special reference to endocrinology, sperm function and in-vitro fertilization. J. Reprod. Fertil. Suppl. 39:73-90.
40. Grosskurth, H., F. Mosha, J. Todd, E. Mwijarubi, A. Klokke, K. Senkoro, P. Mayaud, J. Changalucha, A. Nicoll, G. ka-Gina, J. Newell, K. Mugeye, D. Mabey, and R. Hayes. 1995. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial. Lancet 346:530-536.
41. Gulick, R. M., J. W. Mellors, D. Navlir, J. J. Eron, C. Gonzalez, D. McMahon, D. D. Richman, F. T. Valentine, L. Jonas, A. Meibohm, E. A. Emini, and J. A. Chodakewitz. 1997. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral infection. N. Engl. J. Med. 337:734-739.
42. Gunthard, H. F., J. K. Wong, C. C. Ignacio, J. C. Guatelli, N. L. Riggs, D. V. Havlir, and D. D. Richman. 1998. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J. Virol. 72:2422-2428.
43. Gupta, P., J. Mellors, L. Kingsley, S. Riddler, M. K. Singh, S. Schreiber, M. Cronin, and C. R. Rinaldo. 1997. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J. Virol. 71:6271-6275.
44. Hamed, K. A., M. A. Winters, M. Holodniy, D. A. Katzenstein, and T. C. Merigan. 1993. Detection of human immunodeficiency type 1 in semen: effects of disease stage and nucleoside therapy. J. Infect. Dis. 167:798-802.
45. Hecht, F. M., R. M. Grant, C. J. Petropoulos, B. Dillon, M. A. Chesney, H. Tian, N. S. Hellmann, N. I. Bandrapalli, L. Digilio, B. Branson, and J. O. Kahn. 1998. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N. Engl. J. Med. 339:307-311.
46. Henry, K., B. J. Chinnock, R. P. Quinn, C. V. Fletcher, P. de Miranda, and H. H. Balfour, Jr. 1988. Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complex. JAMA 259:3023-3026.
47. Hirsch, V., N. Riedel, and J. I. Mullins. 1987. The genome organization of STLV-2 is similar to that of the AIDS virus except for a truncated transmembrane protein. Cell 49:307-319.
48. Ho, D. D. 1995. Time to hit HIV, early and hard. N. Engl. J. Med. 333: 450-451.
49. Imrie, A., A. Beveridge, W. Genn, J. Vizzard, D. A. Cooper, and the Sydney Primary HIV Infection Study Group. 1997. Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. J. Infect. Dis. 175:1502-1506.
50. Jacquez, J. A., J. S. Koopma, C. P. Simon, and I. M. Longini, Jr. 1994. Role of the primary infection in epidemics of HIV infection in gay cohorts. J. Acquired Immune Defic. Syndr. 7:1169-1184.
51. Jordan, H. L., J. Howard, R. K. Sellon, D. E. Wildt, W. A. Tomkins, and S. Kennedy-Stoskopf. 1996. Transmission of feline immunodeficiency virus in domestic cats via artificial insemination. J. Virol. 70:8224-8228.
52. Jordan, H. L., J. Howard, W. A. Tompkins, and S. Kennedy-Stoskopf. 1995. Detection of feline immunodeficiency virus in semen from seropositive domestic cats (Felis catus). J. Virol. 69:7328-7333.
53. Kaack, B., W. Lewis, M. I. Resnick, and J. A. Roberts. 1983. Biochemistry of the nonhuman primate prostate and seminal vesicles. I. Some chemical parameters. Arch. Androl. 11:123-129.
54. Kannagi, M., J. M. Yetz, and N. L. Letvin. 1985. In vitro growth characteristics of simian lymphotrophic virus type III. Proc. Natl. Acad. Sci. USA 82:7053-7057.
55. Kararli, T. T. 1995. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos. 16:351-380.
56. Kato, R. 1979. Characteristics and differences in the hepatic mixed function oxidases of different species. Pharmacol. Ther. 6:41-98.
57. King, F. A., C. J. Yarbrough, D. C. Anderson, T. P. Gordon, and K. G. Gould. 1988. Primates. Science 240:1475-1482.
58. Kinlock-de Loes, S., B. J. Hirschel, B. Hoen, D. A. Cooper, B. Tindall, A. Carr, J.-H. Saurat, N. Clumeck, A. Lazzarin, L. Mathieson, F. Raffi, F. Antunes, J. von Overbeck, R. Luthy, M. Glauser, D. Hawkins, C. Baumberger, S. Yerly, T. V. Perneger, and L. Perrin. 1995. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N. Engl. J. Med. 333:408-413.
59. Krieger, J. N., R. W. Coombs, A. C. Collier, D. D. Ho, S. O. Ross, J. E. Zeh, and L. Corey. 1995. Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission. J. Urol. 154:1035-1040.
60. Krieger, J. N., R. W. Coombs, A. C. Collier, S. A. Ross, K. Chaloupka, D. K. Cummings, V. L. Murphy, and L. Corey. 1991. Recovery of HIV-1 from semen: minimal impact of stage of infection and current antiviral therapy. J. Infect. Dis. 163:386-388.
61. Kroodsma, K. L., M. J. Kozal, K. A. Hamed, M. A. Winters, and T. C. Merigan. 1994. Detection of drug resistance mutations in the human immunodeficiency virus type 4 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and proviral DNA. J. Infect. Dis. 170:1292-1295.
62. Lazendorf, S. E., P. M. Gliessman, A. E. Archibong, M. Alexander, and D. P. Wolf. 1990. Collection and quality of rhesus monkey semen. Mol. Reprod. Dev. 25:61-66.
63. Lee, T., G. S. Laco, B. E. Torbett, H. S. Fox, D. L. Lerner, J. H. Elder, and C. H. Wong. 1998. Analysis of the S3 and S3′ subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo. Proc. Natl. Acad. Sci. USA 95:939-944.
64. Lee, T.-H., N. Sakahara, E. Fiebig, M. P. Busch, T. R. O'Brien, and S. A. Herman. 1996. Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 12:427-428.
65. Levy, J. A. 1996. The value of primate models for studying human immunodeficiency virus pathogenesis. J. Med. Primatol. 25:163-174.
66. Lewis, R., M. I. Resnick, B. Kaack, and J. A. Roberts. 1983. Biochemistry of the nonhuman primate prostate and seminal vesicles. II. Molecular weights of soluble proteins. Arch. Androl. 11:131-135.
67. Lewis, R. W., J. C. S. Kim, D. Irani, and J. A. Roberts. 1981. The prostate of the nonhuman primate: normal anatomy and pathology. Prostate 2:51-70.
68. Liuzzi, G., A. Chirianni, M. Clementi, P. Bagnarelli, A. Valenza, P. Tullio Cataldo, and M. Piazza. 1996. Analysis of HIV-1 load in blood, semen, and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 10:F51-F56.
69. Lu, Y., P. Brosio, M. Lafaile, J. Li, R. G. Collman, J. Sodroski, and C. J. Miller. 1996. Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques. J. Virol. 70:3045-3050.
70. Malmborg, A. S. 1978. Antimicrobial drugs in human seminal plasma. J. Antimicrob. Chemother. 4:483-485.
71. Mann, T., and C. Lutwak-Mann. 1982. Passage of chemicals into human and animal semen: mechanisms and significance. Crit. Rev. Toxicol. 11:1-14.
72. Markowitz, M., Y. Cao, M. Vesanen, A. Talal, D. Nixon, A. Hurley, R. O'Donovan, P. Racz, K. Tenner-Racz, and D. D. Ho. 1997. Recent HIV infection treated with AZT, 3TC, and a potent protease inhibitor, abstr. LB 8. In Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, D.C.
73. Matteucci, D., F. Baldinotti, P. Mazzetti, M. Pistello, P. Bandecchi, R. Ghilarducci, A. Poli, F. Tozzini, and M. Bendinelli. 1993. Detection of feline immunodeficiency virus in saliva and plasma by cultivation and polymerase chain reaction. J. Clin. Microbiol. 31:494-501.
74. McDonald, C., and D. R. Kuritzkes. 1997. Human immunodeficiency virus type 1 protease inhibitors. Arch. Intern. Med. 157:951-959.
75. Mehta, S., R. D. Moore, and N. M. H. Graham. 1997. Potential factors affecting adherence with HIV therapy. AIDS 11:1665-1670.
76. Merson, M. H. 1993. Slowing the spread of HIV: agenda for the 1990s. Science 260:1266-1268.
77. Miller, C. J., M. Marthas, J. Torten, N. J. Alexander, J. P. Moore, G. F. Doncel, and A. G. Hendricks. 1994. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J. Virol. 68:6391-6400.
78. Miller, C. J., N. J. Alexander, S. Sutjipto, A. A. Lackner, A. G. Hendrickx, A. Gettie, L. J. Lowenstine, M. Jennings, and P. A. Marx. 1989. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J. Virol. 63: 4277-4284.
79. Miller, C. J., P. Vogel, N. J. Alexander, S. Dandekar, A. G. Hendrickx, and P. A. Marx. 1994. Pathology and localization of simian immunodeficiency virus in the reproductive tract of chronically infected male rhesus macaques. Lab. Investig. 70:255-262.
80. Miller, C. O. 1967. Toxicology: use of nonhuman primates. Science 156: 1772-1773.
81. Milman, G., and O. Sharma. 1994. Mechanisms of HIV/SIV mucosal transmission. AIDS. Res. Hum. Retroviruses 10:1305-1312.
82. Mock, P. A., N. Schaffer, C. Bhadrakom, W. Siriwasin, T. Chotpitayasunondh, S. Chearskul, N. L. Young, A. Roongpisuthipong, P. Shinayon, M. L. Kalish, B. Parekh, T. D. Mastro. 1999. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. AIDS 13:407-414.
83. Moench, T. R., K. J. Whaley, T. D. Mandrell, B. D. Bishop, C. J. Witt, and R. A. Cone. 1993. The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum. AIDS 7:797-802.
84. Molla, A., M. Komeyeva, W. Gao, S. Vasavanonda, P. J. Schipper, H.-M. Mo, M. Markowitz, T. Chernyavskiy, P. Niu, N. Lyons, A. Hsu, G. R. Granneman, D. D. Ho, C. A. B. Boucher, J. M. Leonard, D. W. Norbeck, and D. J. Kempf. 1996. Ordered accumulation of mutations in HIV protease gene confers resistance to ritonavir. Nat. Med. 2:760-766.
85. Mostad, S. B., and J. K. Kreiss. 1996. Shedding of HIV-1 in the genital tract. AIDS 10:1305-1315.
86. Musicco, M., A. Lazzarin, A. Nicolosi, M. Gasparini, P. Costigliola, C. Arici, et al. 1994. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission. Arch. Intern. Med. 154:1971-1976.
87. Nishibe, Y., and M. Hirata. 1995. Induction of cytochrome P450 3A (CYP3A) by E5110, a non-steroidal anti-inflammatory agent (NSAID), and typical CYP3A inducers in primary cultures of dog hepatocytes. Biol. Pharm. Bull. 18:1142-1144.
88. North, T. W., and R. A. LaCasse, 1995. Testing anti-HIV drugs in the FIV model. Nat. Med. 1:410-411.
89. Ogata, H., N. Aoyagi, N. Kaniwa, M. Kolbuchi, T. Shibazaki, A. Ejima, T. Shimamoto, T. Yashiki, Y. Ogawa, Y. Uda, and Y. Nishida. 1982. Correlation of the bioavailability of diazepam from uncoated tablets in beagle dogs with its dissolution rate and bioavailability in humans. Int. J. Clin. Pharmacol. Ther. Toxicol. 20:576-581.
90. O'Neil, L. L., M. J. Burkhard, L. J. Diehl, and E. A. Hoover. 1995. Vertical transmission of feline immunodeficiency virus. AIDS Res. Hum. Retroviruses 1:171-182.
91. Orenstein, J. M., C. Fox, and S. M. Wahl. 1997. Macrophages as a source of HIV during opportunistic infections. Science 276:1857-1861.
92. Patel, B. A., F. D. Boudinot, R. F. Schinazi, J. M. Gallo, and C. K. Chu. 1990. Comparative pharmacokinetics and interspecies scaling of AZT in several mammalian species. J. Pharmacobio-Dyn. 13:206-211.
93. Pereira, A. S., R. R. Tidwell, J. J. Eron, L. Troiani, A. D. M. Kashuba, J. A. Dunn, S. A. Fiscus, J. Schock, R. Shepard, J. E. Hall, and M. S. Cohen. 1999. AZT & 3TC affect excretion of HIV in semen: measurement of antiviral drug concentration in blood and seminal plasma, abstr. 221. In Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, Ill.
94. Phillips, D. M., V. R. Zacharopoulos, X. Tan, and R. Pearce-Pratt. 1994. Mechanisms of sexual transmission of HIV: does HIV infect intact epithelia? Trends Microbiol. 2:454-458.
95. Pichini, S., P. Zuccaro, and R. Pacifici. 1994. Drugs in semen. Clin. Pharmacokinet. 26:356-373.
96. Ping, L. H., J. A. E. Nelson, I. Hoffman, J. Schock, H. Chakraborty, S. Fiscus, J. Eron. Jr., F. Seillier-Moiseiwitsch, P. Vernazza, P. Kazembe, D. Zimba, M. Maida, R. Swanstrom, and M. S. Cohen. 1999. Compartmentalization of subtype C HIV-1 populations between blood and semen as assessed by V3-HTA, abstr 300, p. 125. In Program and abstracts 6th Conference on Retroviruses and Opportunistic Infections. Foundation for Retrovirology and Human Health, Chicago, Ill.
97. Piscitelli, S. C., C. Flexner, J. R. Minor, M. A. Polis, and H. Masur. 1996. Drug interactions in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 23:685-693.
98. Pope, M., S. Gezelter, N. Gallo, L. Hoffman, and R. M. Steinman. 1995. Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ cells. J. Exp. Med. 182:2045-2056.
99. Price, D. 1963. Comparative aspects of development and structure in the prostate. Natl. Cancer Inst. Monogr. 12:1-25.
100. Prueksaritanont, T., S. K. Balani, L. M. Dwyer, J. D. Ellis, L. R. Kauffman, S. L. Varga, S. M. Pitzenberger, and A. D. Theoharides. 1995. Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. Drug. Metab. Dispos. 23:688-695.
101. Quayle, A. J., C. Xu, K. H. Mayer, and D. J. Anderson. 1997. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J. Infect. Dis. 176:960-968.
102. Robb, C. A., P. T. Carroll, L. O. Tippett, and J. B. Langston. 1971. The diffusion of selected sulfonamides, trimethoprim, and diaverdine into prostatic fluid of dogs. Investig. Urol. 8:679-685.
103. Robbins, B. L., J. Rodman, C. McDonald, R. V. Srinivas, P. M. Flynn, and A. Fridland. 1994. Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells. Antimicrob. Agents Chemother. 36:2473-2477.
104. Royce, R. A., A. Sena, W. Cates, Jr., and M. S. Cohen. 1997. Sexual transmission of HIV. N. Engl. J. Med. 336:1072-1078.
105. Rubio, A., M. Leal, J. A. Pineda, A. Caruz, F. Luque, C. Rey, A. Sanchez-Quijano, and E. Lissen. 1997. Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1 infected antiviral-naïve patients from 1989 to 1996. AIDS 11:1184-1186.
106. Schmit, J.-C., J. Cogniaux, P. Hermans, C. van Vaeck, S. Sprecher, B. van Remoortel, M. Witvrouw, J. Balzarini, J. Dosimeter, E. de Clercq, and A.-M. Vandel. 1996. Multiple drug resistance to nucleoside analogues and nonnucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain. J. Infect. Dis. 174: 962-968.
107. Sellon, R. K., H. J. Jordan, S. Kennedy-Stoskopf, M. B. Tompkins, and W. A. Tompkins. 1994. The NCSU, isolate of FIV can be transmitted during acute maternal infection. J. Virol. 68:3380-3385.
108. Sharer, J. E., L. A. Shipley, M. R. Vandenbranden, S. N. Binkley, and S. A. Wrighton. 1995. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metab. Dispos. 23:1231-1241.
109. Shirasaka, T., M. F. Kavlick, T. Ueno, W.-Y. Gao, E. Kohima, M. L. Alcaide, S. Chokekijchai, B. M. Roy, E. Arnold, R. Yarchoan, and H. Mitsuya. 1995. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl. Acad. Sci. USA 92:2398-2402.
110. Smith, E. R. 1975. The canine prostate and its secretion. Adv. Sex. Horm. Res. 1:167-204.
111. Smith, E. R. 1969. The secretion of electrolytes by the pilocarpine-stimulated canine prostate gland. Proc. Soc. Exp. Biol. Med. 132:223-226.
112. Sonnerberg, A., B. Johansson, S. Ayehunie, and I. Julander. 1993. Transmission of zidovudine-resistant HIV-1. AIDS 7:1684-1685.
113. Sperling, R. S., D. E. Shapire, R. W. Coombs, J. A. Todd, S. A. Herman, G. D. McSherry, M. J. O'Sullivan, R. B. Van Dyke, E. Jimenez, C. Rouzioux, and P. M. Flynn for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. 1996. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N. Engl. J. Med. 335:1621-1629.
114. Stewart, P. A., R. Beliveau, and K. A. Rogers. 1996. Cellular localization of P-glycoprotein in brain versus gonadal capillaries. J. Histochem. Cytochem. 44:679-685.
115. Sumartojo, E., J. W. Carey, L. S. Doll, and H. Gayle. 1997. Targeted and general population interventions for HIV prevention: towards a comprehensive approach. AIDS 11:1201-1209.
116. Swinney, D. C. 1990. Progesterone metabolism in hepatic microsomes. Effect of the cytochrome P-450 inhibitor ketoconazole, and the NADPH 5α-reductase inhibitor, 4-MA, upon the metabolic profile in human, monkey, dog, and rat. Drug. Metab. Dispos. 18:859-865.
117. Tan, X., R. Pearce-Pratt, and D. M. Phillips. 1993. Productive infection of a cervical epithelial cell line with human immunodeficiency virus: implications for sexual transmission. J. Virol. 67:6447-6452.
118. Tavares, L., C. Roneker, L. Postie, and F. de Noronha. 1989. Testing of nucleoside analogues in cats infected with feline leukemia virus: a model. Intervirology 30(Suppl. 1):26-35.
119. Taylor, S., D. J. Black, J. Workman, K. Halifax, B. Choudhury, M. Dedicoat, S. M. Drake, D. J. White, G. Beards, P. Cane, and D. Pillay. 1998. Poor penetration of protease inhibitors into semen may impair antiviral activity. AIDS 12:S-27.
120. Tenner-Racz, K., H.-J. Stellbrink, J. van Lunzen, C. Schneider, J.-P. Jacobs, B. Raschdorff, G. Grobschupff, R. M. Steinman, and P. Racz. 1998. The unenlarged lymph nodes of HIV-1 infected asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J. Exp. Med. 187:949-959.
121. Tindall, B., L. Evans, P. Cunningham, P. McQueen, L. Hurren, E. Vasak, J. Mooney, and D. A. Cooper. 1992. Identification of HIV-1 in semen following primary HIV-1 infection. AIDS 6:949-952.
122. Tsai, C. C., K. E. Follis, A. Sabo, T. W. Beck, R. F. Grant, N. Bischof, R. E. Benviniste, and R. Black. 1995. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethopyl) adenine. Science 270:1197-1199.
123. Vernazza, P. L., B. L. Gilliam, J. Dyer, S. A. Fiscus, J. J. Eron, A. Frank, and M. S. Cohen. 1997. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 11:987-993.
124. Vernazza, P. L., B. L. Gilliam, M. Flepp, J. R. Dyer, A. C. Frank, S. A. Fiscus, M. S. Cohen, and J. J. Eron. 1997. Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS 11:1249-1254.
125. Vernazza, P. P., L. Troiani, M. J. Flepp, R. W. Cone, J. Schock, F. Roth, K. Boggian, M. S. Cohen, S. A. Fiscus, J. J. Eron, and the Swiss HIV Cohort Study. Potent antiretroviral treatment of HIV-infection results in suppres-sion of the seminal shedding of HIV. Submitted for publication.
126. Vernazza, P. L., J. J. Eron, M. S. Cohen, C. M. van der Horst, L. Troiani, and S. A. Fiscus. 1994. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS 8:1325-1329.
127. Vernazza, P. L., J. J. Eron, and S. A. Fiscus. 1996. Sensitive method for the detection of infectious HIV in semen of seropositive individuals. J. Virol. Methods 56:33-40.
128. Wainberg, M. A., R. Beaulieu, C. Tsoukas, and R. Thomas. 1993. Detection of zidovudine-resistant variants of HIV-1 in genital fluids. AIDS 7:433-434.
129. Winningham, D. G., N. J. Nemoy, and T. A. Stanley. 1968. Diffusion of antibiotics from plasma into prostatic fluid. Nature 219:139-143.
130. Wolff, H., and D. J. Anderson. 1988. Potential human immunodeficiency virus-host cells in human semen. AIDS Res. Hum. Retroviruses 4:1-2.
131. Wong, J. K., C. C. Ignacio, F. Torriani, D. Havlir, N. J. S. Fitch, and D. D. Richman. 1997. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J. Virol. 71:2059-2071.
132. Wong, J. K., H. F. Gunthard, D. V. Havlir, Z. Zhang, A. T. Haase, C. C. Ignacio, S. Kwok, E. Emini, and D. D. Richman. 1997. Reduction of HIV-1 in blood and lymph nodes following potent anti-retroviral therapy and the virologic correlates of treatment failure. Proc. Natl. Acad. Sci. USA 95: 12574-12579.
133. Xu, C., J. A. Politch, L. Tucker, K. H. Mayer, G. R. Seage III, and D. J. Anderson. 1997. Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen. J. Infect. Dis. 176:941-947.
134. Yamamoto, J. K., E. Sparger, E. W. Ho, P. R. Andersen, P. O'Connor, C. P. Mandell, L. Lowenstine, R. Munn, and N. C. Pedersen. 1988. The pathogenesis of experimentally induced feline immunodeficiency virus (FIV) infection in cats. Am. J. Vet. Res. 49:1246-1258.
135. Yamamoto, J. K., H. Hansen, E. W. Ho, T. Y. Morishita, T. Okuda, T. R. Sawa, R. M. Nakamura, and N. C. Pedersen. 1989. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J. Am. Vet. Med. Assoc. 194:213-220.
136. Yasumori, T., C. Laishun, N. Kiyashi, Y. Yamazoe, and R. Kato. 1993. Species differences in stereoselective metabolism of mephenytoin by cytochrome P450 (CYP2C and CYP3A). J. Pharmacol. Exp. Ther. 264:89-94.
137. Zhang, H., G. Dornadula, and R. J. Pomerantz. 1996. Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenvironments: an important stage for viral infection of nondividing cells. J. Virol. 70:2809-2824.
138. Zhang, H., G. Dornadula, M. Beumont, L. Livornese, B. Van Vitert, K. Henning, and R. J. Pomerantz. 1998. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N. Engl. J. Med. 339:1803-1809.
139. Zhang, L. Q., P. MacKenzie, A. Cleland, E. C. Holmes, A. J. Leigh Brown, and P. Simmonds. 1993. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67:3345-3356.
140. Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179-1181.
141. Zhu, T., N. Wang, A. Carr, D. S. Nam, R. Moor-Jankowski, D. A. Cooper, and D. D. Ho. 1996. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J. Virol. 70:3098-3107.